156 related articles for article (PubMed ID: 28808744)
21. [(18)F-FDG PET/CT: Image-guided surveillance in advanced head and neck cancer as an alternative to neck dissection].
Derlin T
Radiologe; 2016 Sep; 56(9):773-4. PubMed ID: 27502005
[No Abstract] [Full Text] [Related]
22. Comment on: "the FDG PET/CT score" for the diagnosis of malignant pleural effusion.
Malik D
Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):5-6. PubMed ID: 31485682
[No Abstract] [Full Text] [Related]
23. Lack of clinical impact of
Liu J; Larcos G; Howle J; Veness M
Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
[TBL] [Abstract][Full Text] [Related]
24. Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT).
Cameron K; Golan S; Simpson W; Peti S; Roayaie S; Labow D; Kostakoglu L
Abdom Imaging; 2011 Aug; 36(4):463-71. PubMed ID: 21465110
[TBL] [Abstract][Full Text] [Related]
25. DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark.
Jakobsen JK; Alslev L; Ipsen P; Costa JC; Krarup KP; Sommer P; Nerstrøm H; Toft BG; Høyer S; Bouchelouche K; Jensen JB
BJU Int; 2016 Jul; 118(1):102-11. PubMed ID: 26216234
[TBL] [Abstract][Full Text] [Related]
26. Should (18)F FDG PET/CT Really Be Indicated in Routine Clinical Practice for Detecting Contralateral Neck Node Metastasis in Head and Neck Squamous Cell Carcinoma?
Mahajan A; Paul PP; Arya S
Radiology; 2016 Aug; 280(2):651-2. PubMed ID: 27429149
[No Abstract] [Full Text] [Related]
27. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
28. Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT.
Binse I; Rosenbaum-Krumme SJ; Bockisch A
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1185-6. PubMed ID: 26841940
[No Abstract] [Full Text] [Related]
29. Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer.
Zhang S; Li W; Liang F
Oncotarget; 2016 Jul; 7(30):48600-48606. PubMed ID: 27203206
[TBL] [Abstract][Full Text] [Related]
30. Correlation of Ki-67 proliferation index and 18-fluorodeoxyglucose uptake in colorectal incidental lesions detected by positron emission tomography-computed tomography.
Güreşci S; Özmen Ö; Uzman M; Şimşek G; Tatci E; Gökçek A; Yeniova AÖ
Turk J Med Sci; 2016 Jun; 46(4):1182-7. PubMed ID: 27513423
[TBL] [Abstract][Full Text] [Related]
31. eComment. Surgery for isolated adrenal metastasis from non-small-cell lung cancer: the role of preoperative PET/CT scan".
Lococo F; Patricelli G; Galeone C; Rapicetta C
Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):7. PubMed ID: 28052982
[No Abstract] [Full Text] [Related]
32. Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan.
Annunziata S; Calcagni ML; Indovina L; Rufini V
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2140-2141. PubMed ID: 28879394
[No Abstract] [Full Text] [Related]
33. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
34. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
35. Relevance of focal osseous uptake on FDG PET with or without CT changes in oncology patients.
Garg G; DaSilva R; Kim M; Love C; Abraham T
Clin Imaging; 2017; 42():138-146. PubMed ID: 27987478
[TBL] [Abstract][Full Text] [Related]
36. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
Buchs NC; Bühler L; Bucher P; Willi JP; Frossard JL; Roth AD; Addeo P; Rosset A; Terraz S; Becker CD; Ratib O; Morel P
J Gastroenterol Hepatol; 2011 Apr; 26(4):657-62. PubMed ID: 21155879
[TBL] [Abstract][Full Text] [Related]
37. Atypical
Childs L; Thompson A; Jones H; Hameeduddin A; Ghufoor K; Adams A
Clin Imaging; 2018; 49():136-143. PubMed ID: 29414508
[TBL] [Abstract][Full Text] [Related]
38. Fluorodeoxyglucose versus Non-Fluorodeoxyglucose PET-Computed Tomography in Less-Explored Domains: An Appraisal.
Basu S; Kumar R; Alavi A
PET Clin; 2022 Jul; 17(3):xv-xvi. PubMed ID: 35717107
[No Abstract] [Full Text] [Related]
39. Invited editorial for the paper by Silvoniemi et al. "Repeatability of tumor hypoxia imaging using [
Koch CJ
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):159-160. PubMed ID: 29177538
[No Abstract] [Full Text] [Related]
40. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
